Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARROW, INC. Director's Dealing 2020

Oct 1, 2020

31774_dirs_2020-09-30_2a94a747-1df6-468d-b5e4-5d3126d22b39.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARROW HEALTH, INC. (HROW)
CIK: 0001360214
Period of Report: 2020-09-28

Reporting Person: Van Horn R. Lawrence (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-09-28 RSU $0 A 12500 Acquired 2021-09-28 Common Stock (12500) Direct

Footnotes

F1: Award of Restricted Stock Units vests in full on the one-year anniversary from the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service.

F2: The Restricted Stock Units were received as a compensatory award for no consideration..